Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Crinetics Pharmaceuticals
Business Segments
Business Segments
Early Research and Development Programs
Early Research and Development Programs
Crinetics Pharmaceuticals
·
Business Segments
·
1 segment
Breakdown
Segments
Business Segments
View metric
Watchlist
Screener
Filings
Earnings
Charts
Quarterly
Annual
TTM
Segment
Q3 '25
Q1 '26
Business Segments
$9.26M
$9.67M
Total
$9.26M
$9.67M